node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
higB | prlF | b3083 | b3129 | Toxic component of a type II toxin-antitoxin (TA) system. A probable translation-dependent mRNA interferase. Overexpression causes cessation of cell growth and inhibits cell proliferation via inhibition of translation; this blockage is overcome by subsequent expression of antitoxin HigA. Overexpression causes cleavage of a number of mRNAs in a translation-dependent fashion, suggesting this is an mRNA interferase. mRNA interferases play a role in bacterial persistence to antibiotics; overexpression of this protein induces persisters resistant to ciprofloxacin and ampicillin | Antitoxin component of a type II toxin-antitoxin (TA) system. Labile antitoxin that binds to the YhaV toxin and neutralizes its ribonuclease activity. Also acts as a transcription factor. The YhaV/PrlF complex binds the prlF-yhaV operon, probably negatively regulating its expression | 0.732 |
higB | ybaQ | b3083 | b0483 | Toxic component of a type II toxin-antitoxin (TA) system. A probable translation-dependent mRNA interferase. Overexpression causes cessation of cell growth and inhibits cell proliferation via inhibition of translation; this blockage is overcome by subsequent expression of antitoxin HigA. Overexpression causes cleavage of a number of mRNAs in a translation-dependent fashion, suggesting this is an mRNA interferase. mRNA interferases play a role in bacterial persistence to antibiotics; overexpression of this protein induces persisters resistant to ciprofloxacin and ampicillin | Putative dna-binding transcriptional regulator ybaq; Belongs to the VapA/VapI family | 0.699 |
prlF | higB | b3129 | b3083 | Antitoxin component of a type II toxin-antitoxin (TA) system. Labile antitoxin that binds to the YhaV toxin and neutralizes its ribonuclease activity. Also acts as a transcription factor. The YhaV/PrlF complex binds the prlF-yhaV operon, probably negatively regulating its expression | Toxic component of a type II toxin-antitoxin (TA) system. A probable translation-dependent mRNA interferase. Overexpression causes cessation of cell growth and inhibits cell proliferation via inhibition of translation; this blockage is overcome by subsequent expression of antitoxin HigA. Overexpression causes cleavage of a number of mRNAs in a translation-dependent fashion, suggesting this is an mRNA interferase. mRNA interferases play a role in bacterial persistence to antibiotics; overexpression of this protein induces persisters resistant to ciprofloxacin and ampicillin | 0.732 |
prlF | ybaQ | b3129 | b0483 | Antitoxin component of a type II toxin-antitoxin (TA) system. Labile antitoxin that binds to the YhaV toxin and neutralizes its ribonuclease activity. Also acts as a transcription factor. The YhaV/PrlF complex binds the prlF-yhaV operon, probably negatively regulating its expression | Putative dna-binding transcriptional regulator ybaq; Belongs to the VapA/VapI family | 0.593 |
prlF | ydaS | b3129 | b1357 | Antitoxin component of a type II toxin-antitoxin (TA) system. Labile antitoxin that binds to the YhaV toxin and neutralizes its ribonuclease activity. Also acts as a transcription factor. The YhaV/PrlF complex binds the prlF-yhaV operon, probably negatively regulating its expression | Rac prophage; toxin ydas; Uncharacterized protein YdaS; Phage or Prophage Related | 0.476 |
prlF | yfeC | b3129 | b2398 | Antitoxin component of a type II toxin-antitoxin (TA) system. Labile antitoxin that binds to the YhaV toxin and neutralizes its ribonuclease activity. Also acts as a transcription factor. The YhaV/PrlF complex binds the prlF-yhaV operon, probably negatively regulating its expression | Putative dna-binding transcriptional regulator yfec; To E.coli YfiI and P.aeruginosa RluD | 0.511 |
prlF | yfeD | b3129 | b2399 | Antitoxin component of a type II toxin-antitoxin (TA) system. Labile antitoxin that binds to the YhaV toxin and neutralizes its ribonuclease activity. Also acts as a transcription factor. The YhaV/PrlF complex binds the prlF-yhaV operon, probably negatively regulating its expression | annotation not available | 0.483 |
ybaP | ybaQ | b0482 | b0483 | Trab family protein ybap; Uncharacterized protein YbaP; Putative ligase | Putative dna-binding transcriptional regulator ybaq; Belongs to the VapA/VapI family | 0.577 |
ybaQ | higB | b0483 | b3083 | Putative dna-binding transcriptional regulator ybaq; Belongs to the VapA/VapI family | Toxic component of a type II toxin-antitoxin (TA) system. A probable translation-dependent mRNA interferase. Overexpression causes cessation of cell growth and inhibits cell proliferation via inhibition of translation; this blockage is overcome by subsequent expression of antitoxin HigA. Overexpression causes cleavage of a number of mRNAs in a translation-dependent fashion, suggesting this is an mRNA interferase. mRNA interferases play a role in bacterial persistence to antibiotics; overexpression of this protein induces persisters resistant to ciprofloxacin and ampicillin | 0.699 |
ybaQ | prlF | b0483 | b3129 | Putative dna-binding transcriptional regulator ybaq; Belongs to the VapA/VapI family | Antitoxin component of a type II toxin-antitoxin (TA) system. Labile antitoxin that binds to the YhaV toxin and neutralizes its ribonuclease activity. Also acts as a transcription factor. The YhaV/PrlF complex binds the prlF-yhaV operon, probably negatively regulating its expression | 0.593 |
ybaQ | ybaP | b0483 | b0482 | Putative dna-binding transcriptional regulator ybaq; Belongs to the VapA/VapI family | Trab family protein ybap; Uncharacterized protein YbaP; Putative ligase | 0.577 |
ybaQ | ybiH | b0483 | b0796 | Putative dna-binding transcriptional regulator ybaq; Belongs to the VapA/VapI family | Tetr/acrr family transcriptional regulator, regulator of cefoperazone and chloramphenicol sensitivity; Regulates transcription of the cecR-ybhGFSR operon and the rhlE gene, which altogether are involved in the control of sensitivity to cefoperazone and chloramphenicol. Represses the cecR-ybhGFSR operon and activates the rhlE operon. Acts by binding to a palindromic sequence within the intergenic spacer located between these two divergently transcribed operons | 0.731 |
ybaQ | ydaS | b0483 | b1357 | Putative dna-binding transcriptional regulator ybaq; Belongs to the VapA/VapI family | Rac prophage; toxin ydas; Uncharacterized protein YdaS; Phage or Prophage Related | 0.604 |
ybaQ | ydaT | b0483 | b1358 | Putative dna-binding transcriptional regulator ybaq; Belongs to the VapA/VapI family | Rac prophage; protein ydat; Uncharacterized protein YdaT; Phage or Prophage Related | 0.607 |
ybaQ | yeiE | b0483 | b2157 | Putative dna-binding transcriptional regulator ybaq; Belongs to the VapA/VapI family | Putative lysr-type transcriptional regulator yeie; Belongs to the LysR transcriptional regulatory family | 0.737 |
ybaQ | yfeC | b0483 | b2398 | Putative dna-binding transcriptional regulator ybaq; Belongs to the VapA/VapI family | Putative dna-binding transcriptional regulator yfec; To E.coli YfiI and P.aeruginosa RluD | 0.737 |
ybaQ | yfeD | b0483 | b2399 | Putative dna-binding transcriptional regulator ybaq; Belongs to the VapA/VapI family | annotation not available | 0.733 |
ybaQ | yieP | b0483 | b3755 | Putative dna-binding transcriptional regulator ybaq; Belongs to the VapA/VapI family | annotation not available | 0.682 |
ybiH | ybaQ | b0796 | b0483 | Tetr/acrr family transcriptional regulator, regulator of cefoperazone and chloramphenicol sensitivity; Regulates transcription of the cecR-ybhGFSR operon and the rhlE gene, which altogether are involved in the control of sensitivity to cefoperazone and chloramphenicol. Represses the cecR-ybhGFSR operon and activates the rhlE operon. Acts by binding to a palindromic sequence within the intergenic spacer located between these two divergently transcribed operons | Putative dna-binding transcriptional regulator ybaq; Belongs to the VapA/VapI family | 0.731 |
ybiH | yeiE | b0796 | b2157 | Tetr/acrr family transcriptional regulator, regulator of cefoperazone and chloramphenicol sensitivity; Regulates transcription of the cecR-ybhGFSR operon and the rhlE gene, which altogether are involved in the control of sensitivity to cefoperazone and chloramphenicol. Represses the cecR-ybhGFSR operon and activates the rhlE operon. Acts by binding to a palindromic sequence within the intergenic spacer located between these two divergently transcribed operons | Putative lysr-type transcriptional regulator yeie; Belongs to the LysR transcriptional regulatory family | 0.707 |